Equus caballus (horse): 100055670
Help
Entry
100055670 CDS
T01058
Gene name
PLCG2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
ecb
Equus caballus (horse)
Pathway
ecb00562
Inositol phosphate metabolism
ecb01100
Metabolic pathways
ecb01521
EGFR tyrosine kinase inhibitor resistance
ecb04012
ErbB signaling pathway
ecb04014
Ras signaling pathway
ecb04020
Calcium signaling pathway
ecb04062
Chemokine signaling pathway
ecb04064
NF-kappa B signaling pathway
ecb04066
HIF-1 signaling pathway
ecb04070
Phosphatidylinositol signaling system
ecb04072
Phospholipase D signaling pathway
ecb04360
Axon guidance
ecb04370
VEGF signaling pathway
ecb04380
Osteoclast differentiation
ecb04611
Platelet activation
ecb04625
C-type lectin receptor signaling pathway
ecb04650
Natural killer cell mediated cytotoxicity
ecb04662
B cell receptor signaling pathway
ecb04664
Fc epsilon RI signaling pathway
ecb04666
Fc gamma R-mediated phagocytosis
ecb04670
Leukocyte transendothelial migration
ecb04722
Neurotrophin signaling pathway
ecb04750
Inflammatory mediator regulation of TRP channels
ecb04919
Thyroid hormone signaling pathway
ecb04933
AGE-RAGE signaling pathway in diabetic complications
ecb04935
Growth hormone synthesis, secretion and action
ecb05167
Kaposi sarcoma-associated herpesvirus infection
ecb05169
Epstein-Barr virus infection
ecb05170
Human immunodeficiency virus 1 infection
ecb05171
Coronavirus disease - COVID-19
ecb05200
Pathways in cancer
ecb05205
Proteoglycans in cancer
ecb05206
MicroRNAs in cancer
ecb05214
Glioma
ecb05223
Non-small cell lung cancer
ecb05225
Hepatocellular carcinoma
Module
ecb_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
ecb00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
100055670 (PLCG2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
100055670 (PLCG2)
04014 Ras signaling pathway
100055670 (PLCG2)
04370 VEGF signaling pathway
100055670 (PLCG2)
04064 NF-kappa B signaling pathway
100055670 (PLCG2)
04066 HIF-1 signaling pathway
100055670 (PLCG2)
04020 Calcium signaling pathway
100055670 (PLCG2)
04070 Phosphatidylinositol signaling system
100055670 (PLCG2)
04072 Phospholipase D signaling pathway
100055670 (PLCG2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100055670 (PLCG2)
04625 C-type lectin receptor signaling pathway
100055670 (PLCG2)
04650 Natural killer cell mediated cytotoxicity
100055670 (PLCG2)
04662 B cell receptor signaling pathway
100055670 (PLCG2)
04664 Fc epsilon RI signaling pathway
100055670 (PLCG2)
04666 Fc gamma R-mediated phagocytosis
100055670 (PLCG2)
04670 Leukocyte transendothelial migration
100055670 (PLCG2)
04062 Chemokine signaling pathway
100055670 (PLCG2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
100055670 (PLCG2)
04919 Thyroid hormone signaling pathway
100055670 (PLCG2)
09156 Nervous system
04722 Neurotrophin signaling pathway
100055670 (PLCG2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100055670 (PLCG2)
09158 Development and regeneration
04360 Axon guidance
100055670 (PLCG2)
04380 Osteoclast differentiation
100055670 (PLCG2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100055670 (PLCG2)
05206 MicroRNAs in cancer
100055670 (PLCG2)
05205 Proteoglycans in cancer
100055670 (PLCG2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
100055670 (PLCG2)
05214 Glioma
100055670 (PLCG2)
05223 Non-small cell lung cancer
100055670 (PLCG2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
100055670 (PLCG2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100055670 (PLCG2)
05171 Coronavirus disease - COVID-19
100055670 (PLCG2)
05167 Kaposi sarcoma-associated herpesvirus infection
100055670 (PLCG2)
05169 Epstein-Barr virus infection
100055670 (PLCG2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100055670 (PLCG2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
ecb04131
]
100055670 (PLCG2)
Enzymes [BR:
ecb01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
100055670 (PLCG2)
Membrane trafficking [BR:
ecb04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
100055670 (PLCG2)
Endocytosis
Macropinocytosis
Phospholipase C
100055670 (PLCG2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
SH3_9
PH
SH3_2
PH_12
PH_14
EF-hand_like
GDPD
Motif
Other DBs
NCBI-GeneID:
100055670
NCBI-ProteinID:
XP_001502048
Ensembl:
ENSECAG00000000291
VGNC:
21543
LinkDB
All DBs
Position
3
AA seq
1265 aa
AA seq
DB search
MNTMVNVNALPEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETRQVAWSKTADK
IEGFLDIMEIKEIRPGKSSKDFERAKAVRQKEDCCFTILYGTQFVLSTLSLAADSREDAT
KWLSGLKILHQEAMSASTPTIIESWLRKQIYSVDQTRRNSISLRELKTILPLVNFKVSSA
KFLKDKFVEIGAHKDELSFEQFHLFYKKLMFEQQKSILDEFKKDSSVFILGNTDRPDASA
VHLHDFQRFLLHEQQEHWAQDLNRVRERMTKFIDDTMRETAEPFLFVDEFLTYLFSRENS
IWDEKYDVVDMQDMNNPLSHYWISSSHNTYLTGDQLRSESSTEAYIRCLRMGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCGVEQQRHMARV
FKEVFGDQLLMKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNMEDKKDEHKQQGE
LYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTGEEEPPQDTPPTELHFGEKWFHKKVEKR
TSAEKLLQEYCAETGGKDGTFLVRESETFPNDYTLSFWRSGRVQHCRIRSTMEGGTMKYY
LTDNLMFTSIYALIQHYRETHLRCAEFELRLTEPVPNPNPHEAKPWYYDGLSRGEAEDML
MRVPRDGAFLIRKREGTDSYAITFRARGKVKHCRINKDGRHFVLGTSAYFESLVELVSYY
EKHALYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDY
KAKRSDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADVEELEKQII
EDNPLGSLCRGILDLNTYNVVKAPQGKNQKPFVFILEPKKQGDPPVEFATDRVEELFEWF
QSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVE
TKADSVVRQKPIDLLKYNQKGLTRIYPKGQRVDSSNYDPFRFWLCGSQMAALNFQTADKY
MQMNHALFSLNGRTGYVLQPESMRTEKYDPMPPESQRKILMTLTVKVLGARHLPKLGRSI
ACPFVEVEICGAEYDNNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATYPIKGIKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRNANRDALVKEFNVNENQLQLYQEKCNRRLREKRVSN
SKFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgaacaccatggtcaatgtgaacgcccttccggaatacgagaagagtcagatcaagagg
gccctggagctgggcacagtgatgaccgtgttcagcttccgcaagtccacgccggagcgc
aggaccgtccaggtgatcatggagacgcggcaggtggcctggagcaagacggccgacaag
atcgagggcttcttggatatcatggaaataaaggaaatccgcccagggaagagctccaag
gattttgagcgtgcgaaagccgtccgccagaaggaagactgctgcttcaccatcttgtac
ggcacccagttcgtcctcagcacactcagtttggcagctgactctagagaagatgcaact
aagtggctgtctggcttgaaaatcttacaccaggaagcgatgagtgcgtccacacccacc
attattgagagttggctgagaaagcagatttattctgtggatcaaaccagaaggaacagc
atcagcctccgagagttgaagaccatcttgcccctggtcaacttcaaagtgagcagtgcc
aagttcctgaaagataagtttgtggaaataggcgcgcacaaagatgaactcagctttgaa
cagttccatctcttctataaaaaacttatgtttgaacagcaaaagtcgattcttgacgaa
ttcaaaaaggattcttctgtgttcatcttgggcaacaccgaccggccggatgcctccgct
gttcacctgcacgacttccagcggtttctcttacatgaacagcaggaacactgggctcag
gatctgaacagagtccgtgagcggatgacaaagttcatcgacgacacgatgagggaaact
gctgagcccttcttgttcgtcgatgagttcctcacgtacctgttttcacgggagaacagc
atctgggatgagaagtatgacgtggtggacatgcaggacatgaacaaccccttgtcacat
tactggatctcctcatcccacaatacgtacctcacaggtgaccagctgcggagcgagtcg
tccacggaagcgtacatccgctgtctgcggatgggctgtcgctgcatcgagctggactgc
tgggacgggcccgatgggaagcccatcatctaccacggctggacacggaccaccaagatc
aagtttgatgatgtcgtgcaggccatcaaagaccacgcctttgtcacctcgagcttcccc
gtgatcctgtccatcgaggagcactgtggcgtggagcagcagcgccacatggccagggtc
ttcaaggaggtgtttggcgaccagctgctgatgaagcccacggaggccagtgctgaccag
ctgccctcgcccagccagctgcgggagaagatcatcatcaagcataagaagctgggcccc
cgaggcgacgtggatgtcaacatggaggacaagaaggatgaacacaagcaacagggtgaa
ctgtacatgtgggattccattgaccagaaatggactcggcactactgtgccattgctgat
gccaagctgtcctttagcgacgacattgaacagaccggggaagaggagccaccccaggat
acaccccccacagagctgcattttggggagaagtggttccacaagaaggtggagaagagg
acaagtgccgagaagctgctacaggaatactgtgccgagaccgggggcaaggatgggacc
ttcttggtgcgagagagcgagaccttccccaatgactacaccctgtccttctggcggtcg
ggccgcgtccagcactgccggatccgctccaccatggagggcgggaccatgaagtactac
ctgactgacaacctcatgtttaccagcatctacgccctcatccagcattaccgcgagacg
cacctgcgctgcgccgagttcgagcttcggctcaccgagcccgtgcccaaccccaacccc
cacgaggcaaagccgtggtactacgacgggctgagccgcggagaagcagaggacatgctg
atgagggttccccgggacggggccttcctgatccggaagcgggaaggcacggactcctac
gccatcaccttcagggccaggggcaaagtgaagcactgtcgcatcaacaaggacggccgg
cactttgtgctggggacctccgcctacttcgagagcctcgtggagctcgtcagttactac
gagaagcatgcgctctaccgaaagatgaggctgcgctaccccgtgactcccgagctgctg
gagcgctacaatatggaaagagatataaactccctctatgacgtcagcagaatgtatgtg
gatcccagcgaaatcaatccttccatgcctcagagaaccgtgaaagctctgtatgactac
aaagccaagcgaagtgatgagctgagcttctgccgtggcgccctcatccacaacgtctcc
aaggagcccgggggctggtggaaaggagactatgggaccagaatccagcaatactttccg
tctaattacgtcgaggacatctcaacagctgacgtggaggagctggaaaagcagattatt
gaagacaatcccttagggtctctctgcagaggaatattggatctcaacacctataacgtt
gtgaaagccccacaggggaaaaaccagaagcctttcgtctttatcctggagcccaagaag
cagggcgatcctccggtggagtttgccacggacagggtggaggagctctttgagtggttt
cagagcatccgggagatcacctggaagatcgacaccaaggagaacaacatgaagtactgg
gagaagaaccagtcgatcgccatcgagctctcagacctggtcgtctactgcaagccaacc
agcaagaccaaggacaatttagaaaaccccgacttccgagaaatccgctcgtttgtggag
acgaaggcggacagtgtggtcagacagaaacccatcgatctcctgaagtacaatcaaaag
ggcctgacccgcatttaccccaagggacagagggtggactcctccaactacgaccccttc
cgcttctggctgtgtggctcccagatggcggcactcaatttccagactgcagataagtac
atgcagatgaaccacgccttgttttcactcaatgggcggacgggctacgtcctacagcct
gagagcatgaggacggagaagtacgaccccatgccgcccgagtcccagaggaagatcctg
atgactttgacggtcaaggttcttggggctcgccatctccccaaacttggacggagtatt
gcatgtccctttgtggaggtggaaatatgtggagccgaatatgacaacaacaagtttaag
acgacagttgtgaatgacaatggcctaagccctgtttgggctccaacacaggagaaggtg
acgtttgaaatttatgacccaaacctcgcgtttctgcgctttgtggtttatgaggaagat
atgttcagtgatcccaactttcttgctcatgccacttaccccattaaagggatcaaatca
ggatttagatctgttcctctgaagaatgggtacagtgaagacattgagctggcttccctc
ctggttttctgtgagatgcggcccgtcctggagagcgaagaggaactctactcctcctgt
cgccagctgcggaggcggcaggaagagctgaacaaccagctctttctgtacgacacacac
cagaacttgcgcaatgccaaccgggatgccctcgttaaagagttcaacgtcaacgagaac
cagctccagctgtaccaggagaagtgcaaccggaggttaagagagaagagagtgagcaac
agcaagttttactcctag
Equus caballus (horse): 100070545
Help
Entry
100070545 CDS
T01058
Gene name
PLCG1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
ecb
Equus caballus (horse)
Pathway
ecb00562
Inositol phosphate metabolism
ecb01100
Metabolic pathways
ecb01521
EGFR tyrosine kinase inhibitor resistance
ecb04012
ErbB signaling pathway
ecb04014
Ras signaling pathway
ecb04015
Rap1 signaling pathway
ecb04020
Calcium signaling pathway
ecb04062
Chemokine signaling pathway
ecb04064
NF-kappa B signaling pathway
ecb04066
HIF-1 signaling pathway
ecb04070
Phosphatidylinositol signaling system
ecb04072
Phospholipase D signaling pathway
ecb04360
Axon guidance
ecb04370
VEGF signaling pathway
ecb04650
Natural killer cell mediated cytotoxicity
ecb04658
Th1 and Th2 cell differentiation
ecb04659
Th17 cell differentiation
ecb04660
T cell receptor signaling pathway
ecb04664
Fc epsilon RI signaling pathway
ecb04666
Fc gamma R-mediated phagocytosis
ecb04670
Leukocyte transendothelial migration
ecb04722
Neurotrophin signaling pathway
ecb04750
Inflammatory mediator regulation of TRP channels
ecb04919
Thyroid hormone signaling pathway
ecb04933
AGE-RAGE signaling pathway in diabetic complications
ecb04935
Growth hormone synthesis, secretion and action
ecb05012
Parkinson disease
ecb05022
Pathways of neurodegeneration - multiple diseases
ecb05135
Yersinia infection
ecb05167
Kaposi sarcoma-associated herpesvirus infection
ecb05170
Human immunodeficiency virus 1 infection
ecb05171
Coronavirus disease - COVID-19
ecb05200
Pathways in cancer
ecb05205
Proteoglycans in cancer
ecb05206
MicroRNAs in cancer
ecb05214
Glioma
ecb05223
Non-small cell lung cancer
ecb05225
Hepatocellular carcinoma
ecb05231
Choline metabolism in cancer
ecb05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
ecb_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
ecb00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
100070545 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
100070545 (PLCG1)
04014 Ras signaling pathway
100070545 (PLCG1)
04015 Rap1 signaling pathway
100070545 (PLCG1)
04370 VEGF signaling pathway
100070545 (PLCG1)
04064 NF-kappa B signaling pathway
100070545 (PLCG1)
04066 HIF-1 signaling pathway
100070545 (PLCG1)
04020 Calcium signaling pathway
100070545 (PLCG1)
04070 Phosphatidylinositol signaling system
100070545 (PLCG1)
04072 Phospholipase D signaling pathway
100070545 (PLCG1)
09150 Organismal Systems
09151 Immune system
04650 Natural killer cell mediated cytotoxicity
100070545 (PLCG1)
04660 T cell receptor signaling pathway
100070545 (PLCG1)
04658 Th1 and Th2 cell differentiation
100070545 (PLCG1)
04659 Th17 cell differentiation
100070545 (PLCG1)
04664 Fc epsilon RI signaling pathway
100070545 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
100070545 (PLCG1)
04670 Leukocyte transendothelial migration
100070545 (PLCG1)
04062 Chemokine signaling pathway
100070545 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
100070545 (PLCG1)
04919 Thyroid hormone signaling pathway
100070545 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
100070545 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100070545 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
100070545 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100070545 (PLCG1)
05206 MicroRNAs in cancer
100070545 (PLCG1)
05205 Proteoglycans in cancer
100070545 (PLCG1)
05231 Choline metabolism in cancer
100070545 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100070545 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
100070545 (PLCG1)
05214 Glioma
100070545 (PLCG1)
05223 Non-small cell lung cancer
100070545 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
100070545 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
100070545 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
100070545 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
100070545 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100070545 (PLCG1)
05171 Coronavirus disease - COVID-19
100070545 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
100070545 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100070545 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
ecb04131
]
100070545 (PLCG1)
Enzymes [BR:
ecb01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
100070545 (PLCG1)
Membrane trafficking [BR:
ecb04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
100070545 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
100070545 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
SH3_9
PH
SH3_2
GDPD
PH_9
Motif
Other DBs
NCBI-GeneID:
100070545
NCBI-ProteinID:
XP_005604689
Ensembl:
ENSECAG00000021031
VGNC:
21542
LinkDB
All DBs
Position
22
AA seq
1160 aa
AA seq
DB search
MWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRISAKDLKNMLSQVNYRVPNM
RFLRERLTDLEQRSSDITYGQFAQLYRSLMYSAQKTMDLPFLEASALRAGERPELCRVSL
PEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSVWN
SQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDG
PDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIAQQRNMAQYFKK
VLGDTLLTKPVDIAADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSVMYSENDISNSIK
NGILYLEDPVNHEWYPHYFVLTSSKIYYSEETNSDQGNEDEEEPKETSGSTELHSNEKWF
HGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIH
SRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHA
SLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEF
DSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPT
FKCAVKALFDYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVS
PAALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMASMAHWSLDV
AADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYCRPVPFDEEKIG
TERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWIC
GSQLVALNFQTPDKPMQMNQALFMAGGHCGYVLQPSTMRDEAFDPFDKSSLRGLEPCAIC
IEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVWPAKPFHFQISN
PEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLELASLLVKIDV
FPAKQENGDLSPFSGTSLRERGSDASGQLFHGRAREGSFEARYQQPFEDFRISQEHLADH
FDSRERRAPRRTRVNGDNRL
NT seq
3483 nt
NT seq
+upstream
nt +downstream
nt
atgtggatcaagggcttaacttggttgatggaggatactttgcaggcggccacacccctg
cagattgagaggtggctgcggaagcagttctactcagtggatcgaaaccgtgaggaccgt
atatcagccaaggacctgaagaacatgctgtcccaggtcaactaccgggtccccaacatg
cgcttccttcgagagcggctaacggacctggagcagcgcagcagcgacatcacctatggg
cagtttgctcagctgtaccgcagcctcatgtacagcgcccagaagacgatggacctccct
ttcttggaagccagtgccctgagggctggggagcggccagagctctgccgagtgtcactt
cctgagttccagcagtttctcctcgagtaccagggggagctgtgggctgttgaccggctc
caggtgcaggagtttatgctcagcttcctcagagaccccttgcgagagattgaggagcca
tacttcttcctggacgagttcgtcaccttcctattctccaaagagaacagtgtgtggaac
tcacagctggatgcagtgtgcccagacaccatgaacaaccctctctctcactactggatc
tcctcctcgcacaatacgtatctgaccggggaccagttctccagcgagtcctccctggaa
gcctatgctcgctgcctgcggatgggctgtcgctgcattgagttggactgttgggacggc
ccagacgggatgcctgtcatttaccacggacacacccttaccaccaagatcaagttctca
gatgtcctgcacaccatcaaggagcatgcctttgtggcctcagagtacccggtcatcctg
tccatcgaggaccactgcagtattgcccagcaaaggaacatggcccagtacttcaagaag
gtgctcggggacacactcctcaccaagcctgtggacatcgccgcagatgggctgccttca
cccaatcagctcaagaggaagatccttatcaagcacaagaagctggctgagggtagtgcc
tatgaggaggtgcctacatctgtgatgtactcagagaacgacatcagcaactccatcaag
aatggcatcctctacctggaggaccctgtgaaccatgagtggtatccccactactttgtt
ctgaccagcagcaagatctactactctgaggagaccaacagtgaccagggcaatgaggat
gaggaggagcccaaggagaccagcggcagcacagagctgcactccaacgagaagtggttc
catgggaagctcggggcaggacgggacgggcggcacatcgccgagcgcctgctcaccgag
tactgcattgagaccggggcccccgatggctccttcctagtgcgcgagagcgagaccttt
gtgggcgactacaccctctctttctggcggaacgggaaagtccagcactgcaggatccac
tctcggcaggatgctgggacccccaagttcttcttaacagacaacctcgtctttgactcc
ctctatgacctcatcacacactaccagcaggtgcccctgcgctgcaacgaatttgagatg
cgcctctcagagcctgtcccacagaccaatgcccacgagagcaaagagtggtaccacgca
agcctgaccagagcacaggctgagcacatgctgatgcgtgtcccccgtgatggtgcattc
ctggtgcggaaacggaatgagcccaactcttacgccatatccttccgggccgagggcaag
attaagcattgccgtgtccagcaggagggccagactgtgatgctgggcaactcggagttt
gacagcctcgttgacctcatcagctactatgagaagcatccgctgtaccgcaagatgaaa
ctgcgctatcccatcaacgaggaggcgctggagaagattggcacagctgagcctgactac
ggggccctgtatgagggacgcaaccctggcttctatgtggaagcaaaccctatgccgact
ttcaagtgtgcagttaaagccctctttgactacaaggcccagagagaggatgagctgact
ttcaccaagagcgccatcatccagaatgtggagaagcaagagggaggctggtggcgaggg
gactatggtgggaagaagcagctgtggttcccatccaactacgtggaagaaatggtcagt
ccagcggccctggagcctgaaagggagcacttggacgagaacagccctctgggggacttg
ctgcggggggtcttggatgtgccagcttgtcagattgccatccgtcctgagggcaagaac
aaccggctcttcgtcttctccatcagcatggcgtccatggcacactggtccctggatgtt
gctgctgactctcaggaggagctgcaggactgggtgaaaaagatccgagaagtggcccag
accgcagatgccaggctcactgaggggaagatgatggaacggaggaagaagattgccctg
gagctctccgagcttgttgtctactgccgacctgttccttttgatgaagagaagattggc
acagaacgtgcctgctaccgggacatgtcatcctttccggaaaccaaggctgagaaatat
gtgaacaaggccaaaggcaagaagttcctccagtacaaccggctccagctctcccgcatc
taccccaagggccagcggctggactcctccaattacgatcccttgcccatgtggatctgt
ggcagtcagctggtggccctcaacttccagaccccagacaagcctatgcagatgaaccag
gccctcttcatggccggcgggcactgtggctacgtgctgcagccaagcaccatgcgggac
gaggccttcgacccctttgacaagagcagcctccgtgggctagagccatgcgccatctgc
atcgaggtgctgggggcccggcatctgccaaagaatggccgaggcattgtgtgtcctttt
gtggagattgaggtggctggagctgagtatgacagcaccaagcagaagacagagtttgtg
gtggacaatggactgaaccccgtgtggccagccaagcccttccacttccagatcagtaac
cccgaattcgccttcctgcgctttgtagtgtatgaggaagacatgtttagtgaccagaac
ttcctggcccaggctactttcccggtgaaaggcctgaagacaggatatagagcggtgcct
ttgaaaaacaactacagtgaggacctggagctggcctccctgctcgtcaagatcgacgtt
ttccctgccaagcaggagaacggcgacctcagtcccttcagtggtacgtccctgcgggaa
cggggctctgatgcctcgggccagctgtttcatggccgggcccgggaaggctcctttgaa
gcccgctaccagcagccatttgaggactttcgcatctcccaggagcaccttgcagaccat
tttgacagtcgggaacgaagggccccacgaaggactcgggtcaacggagacaatcgcctc
tag
DBGET
integrated database retrieval system
